Your browser doesn't support javascript.
loading
Adverse impact of delay of platelet recovery after autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma and multiple myeloma.
Okada, Yosuke; Kimura, Fumihiko; Kurita, Naoki; Takahashi, Hiroyuki; Shimazu, Yutaka; Mizuno, Shohei; Uchida, Naoyuki; Kataoka, Keisuke; Hiramoto, Nobuhiro; Ota, Shuichi; Kako, Shinichi; Tsukada, Nobuhiro; Kanda, Yoshinobu; Kurahashi, Shingo; Doki, Noriko; Nishikawa, Akinori; Kim, Sung-Won; Hangaishi, Akira; Kanda, Junya; Fukuda, Takahiro; Atsuta, Yoshiko; Kondo, Eisei; Kawamura, Koji; Nakasone, Hideki.
Afiliación
  • Okada Y; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan.
  • Kimura F; Division of Hematology, National Defense Medical College, Tokorozawa, Japan.
  • Kurita N; Department of Hematology, University of Tsukuba Hospital, Tsukuba, Ibaraki, Japan; Department of Hematology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.
  • Takahashi H; Department of Hematology and Medical Oncology, Kanagawa Cancer Center, Yokohama, Japan.
  • Shimazu Y; Department of Hematology, Kyoto University Hospital, Kyoto, Japan.
  • Mizuno S; Division of Hematology, Department of Internal Medicine, Aichi Medical University, Nagakute, Japan.
  • Uchida N; Department of Hematology, Federation of National Public Service Personnel Mutual Aid Associations, Toranomon Hospital, Tokyo, Japan.
  • Kataoka K; Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.
  • Hiramoto N; Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan.
  • Ota S; Department of Hematology, Sapporo Hokuyu Hospital, Sapporo, Hokkaido, Japan.
  • Kako S; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan.
  • Tsukada N; Division of Hematology, Japanese Red Cross Medical Center, Tokyo, Japan.
  • Kanda Y; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan; Division of Hematology, Jichi Medical University, Tochigi, Japan.
  • Kurahashi S; Division of Hematology and Oncology, Toyohashi Municipal Hospital, Toyohashi, Japan.
  • Doki N; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
  • Nishikawa A; Department of Hematology/Oncology, Wakayama Medical University, Wakayama, Japan.
  • Kim SW; Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
  • Hangaishi A; Department of Hematology, National Center for Global Health and Medicine, Tokyo, Japan.
  • Kanda J; Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Tokyo, Japan.
  • Fukuda T; Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
  • Atsuta Y; Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Aichi, Japan; Department of Registry Science for Transplant and Cellular Therapy, Aichi Medical University School of Medicine, Nagakute, Aichi, Japan.
  • Kondo E; Department of Hematology, Kawasaki Medical School, Kurashiki, Japan.
  • Kawamura K; Department of Hematology, Tottori University Hospital, Yonago, Japan.
  • Nakasone H; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan. Electronic address: nakasone-tky@umin.ac.jp.
Cytotherapy ; 25(11): 1212-1219, 2023 11.
Article en En | MEDLINE | ID: mdl-37354150
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Linfoma no Hodgkin / Trasplante de Células Madre Hematopoyéticas / Mieloma Múltiple Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Cytotherapy Asunto de la revista: TERAPEUTICA Año: 2023 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Linfoma no Hodgkin / Trasplante de Células Madre Hematopoyéticas / Mieloma Múltiple Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Cytotherapy Asunto de la revista: TERAPEUTICA Año: 2023 Tipo del documento: Article País de afiliación: Japón